1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for Japan Next Generation Cancer Diagnostics Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in Japan Next Generation Cancer Diagnostics Market
4. Japan Next Generation Cancer Diagnostics Market by Technology
4.1. QPCR and Multiplexing
4.2. Benchtop Sequencers
4.3. Lab-on-a-chip
4.4. Next Generation Sequencing
4.5. Protein Microarrays
4.6. DNA Microarrays
4.7. Other
5. Japan Next Generation Cancer Diagnostics Market by Application
5.1. Biomarker Development
5.2. Proteomic Analysis
5.3. CTC Analysis
5.4. Genetic Analysis
5.5. Epigenetic Analysis
6. Japan Next Generation Cancer Diagnostics Market by Cancer Type
6.1. Lung Cancer
6.2. Colorectal Cancer
6.3. Breast Cancer
6.4. Prostate Cancer
6.5. Others
7. Japan Next Generation Cancer Diagnostics Market by Function
7.1. Cancer Screening
7.2. Therapeutic Monitoring
7.3. Prognosis Diagnostics
7.4. Risk Analysis
7.5. Companion Diagnostics
8. Company Profiles
8.1. Company 1
8.2. Company 2
8.3. Company 3
8.4. Company 4
8.5. Company 5
1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for Japan Next Generation Cancer Diagnostics Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in Japan Next Generation Cancer Diagnostics Market
4. Japan Next Generation Cancer Diagnostics Market by Technology
4.1. QPCR and Multiplexing
4.2. Benchtop Sequencers
4.3. Lab-on-a-chip
4.4. Next Generation Sequencing
4.5. Protein Microarrays
4.6. DNA Microarrays
4.7. Other
5. Japan Next Generation Cancer Diagnostics Market by Application
5.1. Biomarker Development
5.2. Proteomic Analysis
5.3. CTC Analysis
5.4. Genetic Analysis
5.5. Epigenetic Analysis
6. Japan Next Generation Cancer Diagnostics Market by Cancer Type
6.1. Lung Cancer
6.2. Colorectal Cancer
6.3. Breast Cancer
6.4. Prostate Cancer
6.5. Others
7. Japan Next Generation Cancer Diagnostics Market by Function
7.1. Cancer Screening
7.2. Therapeutic Monitoring
7.3. Prognosis Diagnostics
7.4. Risk Analysis
7.5. Companion Diagnostics
8. Company Profiles
8.1. Company 1
8.2. Company 2
8.3. Company 3
8.4. Company 4
8.5. Company 5